Inbiose
0534.887.593 · rovalta.com · 21/09/2026
ACTIVE
Inbiose
Financial year 2025 · closed on 31/12/2025
Net result
-1,6 M €
+58.0% YoY
Revenue
6,3 M €
+209.2% YoY
Equity
3,6 M €
+152.5% YoY
Workforce
46,1 ETP
-10.1% YoY
Overview
What does Inbiose do?
Inbiose is a Public limited company incorporated in 2013. Its main activity is: Manufacture of other chemical products n.e.c.. Its registered office is in Gent. It employs on average 46,1 ETP workers (FTE).
Legal situation
● Normal situation
BCE/KBO no. / VAT
BE 0534.887.593
Incorporation
31/05/2013
Legal form
Public limited company
Registered office
Technologiepark-Zwijnaarde 82 box 41
9052 Gent · FlandreSee on map
9052 Gent · FlandreSee on map
Contributed capital
5 138 260,33 €
Latest accounts
31/12/2025
Average workforce
46,1 ETP
Activities (NACE)
20590Manufacture of other chemical products n.e.c.· main20590Manufacture of other chemical products n.e.c.72101Research and experimental development on natural sciences and engineering72110Research and experimental development on biotechnology72101Research and experimental development on natural sciences and engineering72110Research and experimental development on biotechnology+4
Joint committees (2)
- 207
- 20700
Signals
Good liquidityPositive cashflowPositive EBITDAHealthy social debtsHigh revenue
Available with a Rovalta subscriptionTry for 7 days
Financials
Trend over 12 financial years
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||||||||||||||||
| Revenue | 6,3 M € | +209% | 2 M € | +62.6% | 1,3 M € | – | – | – | – | – | – | – | – | – | |||||||||
| EBITDA | 2,4 M € | +322% | -1,1 M € | +43.4% | -1,9 M € | +11.0% | -2,1 M € | -41.6% | -1,5 M € | -407% | -294,2 k € | -117% | 1,7 M € | -22.4% | 2,2 M € | -8.5% | 2,4 M € | +31.7% | 1,8 M € | +66.0% | 1,1 M € | +13043% | 8,3 k € |
| Operating result | -690,4 k € | +74.5% | -2,7 M € | +5.0% | -2,9 M € | +54.1% | -6,2 M € | -7.5% | -5,8 M € | -11.7% | -5,2 M € | -99.5% | -2,6 M € | -367% | -555,5 k € | -640% | 102,8 k € | -82.4% | 585,2 k € | -23.0% | 760,2 k € | +636% | -141,9 k € |
| Net result | -1,6 M € | +58.0% | -3,8 M € | -14.3% | -3,3 M € | +49.1% | -6,5 M € | -13.1% | -5,8 M € | -11.2% | -5,2 M € | -114% | -2,4 M € | -322% | -573,5 k € | -765% | -66,3 k € | -108% | 846,8 k € | -13.9% | 983,4 k € | +19363% | 5,1 k € |
| Balance sheet | |||||||||||||||||||||||
| Equity | 3,6 M € | +153% | -6,9 M € | -121% | -3,1 M € | +49.4% | -6,2 M € | -2026% | 321,9 k € | -94.7% | 6,1 M € | -46.0% | 11,3 M € | +98.0% | 5,7 M € | -9.5% | 6,3 M € | +22.5% | 5,1 M € | +62.2% | 3,2 M € | +2198% | 137,6 k € |
| Total assets | 17,2 M € | +26.9% | 13,5 M € | +23.8% | 10,9 M € | +52.7% | 7,2 M € | -37.1% | 11,4 M € | +10.4% | 10,3 M € | -21.3% | 13,1 M € | +82.9% | 7,2 M € | -14.4% | 8,4 M € | +30.2% | 6,4 M € | +60.4% | 4 M € | +1602% | 235,5 k € |
| Cash | 1,6 M € | +109% | 784,7 k € | +27.2% | 617,1 k € | -41.8% | 1,1 M € | -81.3% | 5,7 M € | -1.6% | 5,8 M € | -39.8% | 9,6 M € | +128% | 4,2 M € | -7.0% | 4,5 M € | -6.7% | 4,9 M € | +73.5% | 2,8 M € | +2328% | 115,2 k € |
| Debts | 13,4 M € | -34.4% | 20,3 M € | +46.1% | 13,9 M € | +5.1% | 13,3 M € | +20.9% | 11 M € | +160% | 4,2 M € | +155% | 1,7 M € | +12.6% | 1,5 M € | -29.0% | 2,1 M € | +99.9% | 1 M € | +59.2% | 651,3 k € | +1056% | 56,4 k € |
| Other | |||||||||||||||||||||||
| Workforce | 46,1 ETP | -10.1% | 51,3 ETP | -4.5% | 53,7 ETP | +0.4% | 53,5 ETP | +3.1% | 51,9 ETP | +10.4% | 47,0 ETP | +8.5% | 43,3 ETP | +25.9% | 34,4 ETP | +26.5% | 27,2 ETP | +98.5% | 13,7 ETP | +315% | 3,3 ETP | +32.0% | 2,5 ETP |
Estimate
Indicative valuation
As an indication, this company is worth
between 0 € and 100 k€
See the valuationGovernance
Board of directors
Seen on filing of 31/12/2025 · 10 active · 28 ended
Active mandates
Pelin Yilmaz
ActiveJakub Kalinowksi
ActiveDirk Abeel Consulting BV
ActiveClemence Delcourt
ActiveActive
Jean Prevot
ActiveJoeri Beauprez
ActiveMarcus Florent Oscar Zabeau
ActiveActive
Ended mandates
Hendrik WAEGEMAN
EndedJoeri BEAUPREZ
EndedMarc ZABEAU
EndedAt this address
Other companies at this address
| Company | CBE no. |
|---|---|
Amalus Therapeutics● Bankrupt | 0803.929.268 |
APCOR R&M● Active | 0600.952.909 |
Ardoyen● Active | 0875.102.821 |
AVROXA● Active | 0687.774.936 |
Benebiose● Active | 0784.521.548 |
BioNeering● Active | 0807.194.309 |
CONTREL EUROPE● Active | 0426.204.637 |
CRODEON TECHNOLOGIES● Active | 0642.754.761 |
Cryptobiotix● Active | 0762.565.104 |
Gulliver Biomed● Active | 0692.527.837 |
ImplicitMeasures.com● Bankrupt | 0657.989.701 |
| 0440.054.752 | |
INNOVATIVE PHARMACEUTICS● Active | 0883.574.582 |
Inspect● Active | 0645.950.417 |
INVIBES ADVERTISING● Active | 0836.533.938 |
KYTOS● Active | 0768.755.286 |
Lares Solutions● Active | 1015.346.906 |
| 0755.350.975 | |
| 0742.910.132 | |
| 0667.765.816 |
Financials
Annual accounts
Full financial information
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Type of account | Full model | Full model | Full model | Abridged model | Abridged model | Abridged model |
| Start of the financial year | 01/01/2025 | 01/01/2024 | 01/01/2023 | 01/01/2022 | 01/01/2021 | 01/01/2020 |
| Closing of the financial year | 31/12/2025 | 31/12/2024 | 31/12/2023 | 31/12/2022 | 31/12/2021 | 31/12/2020 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 12 months | 12 months |
| Filing date | 10/07/2026 | 15/07/2025 | 07/06/2024 | 23/06/2023 | 20/07/2022 | 07/07/2021 |
| General meeting | 12/06/2026 | 26/06/2025 | 27/05/2024 | 12/06/2023 | 25/05/2022 | 25/05/2021 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Ratios
Financial ratios
Looking for more information about this company?
Try for 7 daysFilings
Annual accounts filings
13 filings with the NBB
| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Full model | 31/12/2025 | 12/06/2026 | 10/07/2026 | Dutch | |
| Full model | 31/12/2024 | 26/06/2025 | 15/07/2025 | Dutch | |
| Full model | 31/12/2023 | 27/05/2024 | 07/06/2024 | Dutch | |
| Abridged model | 31/12/2022 | 12/06/2023 | 23/06/2023 | Dutch | |
| Abridged model | 31/12/2021 | 25/05/2022 | 20/07/2022 | Dutch | |
| Abridged model | 31/12/2020 | 25/05/2021 | 07/07/2021 | Dutch | |
| Abridged model | 31/12/2019 | 25/05/2020 | 10/06/2020 | Dutch | |
| Abridged model | 31/12/2018 | 29/05/2019 | 07/06/2019 | Dutch | |
| Abridged model | 31/12/2017 | 25/05/2018 | 30/05/2018 | Dutch | |
| Abridged modelCorrection | 31/12/2016 | 24/05/2017 | 22/11/2017 | Dutch | |
| Abridged model | 31/12/2016 | 24/05/2017 | 22/06/2017 | Dutch | |
| Abridged model | 31/12/2015 | 25/05/2016 | 02/06/2016 | Dutch | |
| Abridged model | 31/12/2014 | 26/05/2015 | 31/07/2015 | Dutch |
Valuation
Estimate
Indicative valuation
Order of magnitude
As an indication, this company is worth
between 0 € and 100 k€
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Disclaimer
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Governance
Board of directors
Seen on filing of 31/12/2025 · 10 active · 28 ended
Active mandates
Pelin Yilmaz
ActiveJakub Kalinowksi
ActiveDirk Abeel Consulting BV
ActiveClemence Delcourt
ActiveActive
Jean Prevot
ActiveJoeri Beauprez
ActiveMarcus Florent Oscar Zabeau
ActiveActive
Ended mandates
Hendrik WAEGEMAN
EndedJoeri BEAUPREZ
EndedMarc ZABEAU
EndedShareholders
Ownership and network
Looking for more information about this company?
Try for 7 daysPublications
Belgian Official Gazette
Belgian Official Gazette publications
- Mandates22/05/2026KAPITAAL - AANDELEN - ONTSLAGEN - BENOEMINGEN
- Mandates20/03/2026ONTSLAGEN - BENOEMINGEN
- Mandates13/08/2025STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, ) - DIVERSEN - KAPITAAL - AANDELEN - ONTSLAGEN - BENOEMINGEN
- Capital / shares23/08/2023KAPITAAL - AANDELEN
- Capital / shares28/06/2023KAPITAAL - AANDELEN
- Capital / shares12/06/2023KAPITAAL - AANDELEN - STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, )
- Mandates28/07/2022ONTSLAGEN - BENOEMINGEN
- Other10/06/2021STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, )
Source: Belgian Official Gazette
Similar companies
Competition
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
- 2025Annual accounts 2025-1,6 M €↑
- 2024Annual accounts 2024-3,8 M €↓
- 2023Annual accounts 2023-3,3 M €↑
- 2022Annual accounts 2022-6,5 M €↓
- 2021Annual accounts 2021-5,8 M €↓
- 2020Annual accounts 2020-5,2 M €↓
- 2019Annual accounts 2019-2,4 M €↓
- 2018Annual accounts 2018-573,5 k €↓
- 2017Annual accounts 2017-66,3 k €↓
- 2016Annual accounts 2016846,8 k €↓
- 2015Annual accounts 2015983,4 k €↑
- 2014Annual accounts 20145,1 k €
- 31/05/2013IncorporationPublic limited company